Skip directly to Accessibility Notice

How to Purchase

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 04/09/20

  • 30-Day SEC Yield1

    1.79%
  • Total Net Assets

    $194.3M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.42%
  • Net Expense Ratio/TER2

    0.36%
  • Distribution Frequency

    Quarterly
  • Next Distribution Date

    06/30/2020

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    3,388,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.07%
  • Gross Expense Ratio

    0.42%
  • Fee Waivers and
    Expense Reimbursement

    -0.06%
  • Net Expense Ratio/TER2

    0.36%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2021. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Prices as of 04/09/20

NAV/
Market Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
30-Day
Median
Bid Ask
Spread
NAV
Chart
PPH $57.35
$57.41
126,399
33,531
$0.96 / +1.70%
$1.13 / +2.01%
-9.93%
-9.75%
$0.06
0.10%
--

Premium/Discount History as of 04/09/20

Calendar Year 2019 2Q 2019 3Q 2019 4Q 2019 1Q 2020 Premium/Discount Charts NAV & Prem/Discount History
Days closed at a premium 88 23 23 26 22
PPH Days closed at NAV 22 6 2 5 5
Days closed at a discount 142 34 39 33 35

Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) -7.85 -15.01 -15.01 -8.59 1.50 -3.07 -- 7.34
PPH (Share Price) -7.89 -15.02 -15.02 -8.69 1.48 -3.10 -- 7.45
MVPPHTR (Index) -7.93 -15.37 -15.37 -8.88 1.39 -3.11 -- 7.27
Performance Differential (NAV - Index) 0.08 0.36 0.36 0.29 0.11 0.04 -- 0.07
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) -7.85 -15.01 -15.01 -8.59 1.50 -3.07 -- 7.34
PPH (Share Price) -7.89 -15.02 -15.02 -8.69 1.48 -3.10 -- 7.45
MVPPHTR (Index) -7.93 -15.37 -15.37 -8.88 1.39 -3.11 -- 7.27
Performance Differential (NAV - Index) 0.08 0.36 0.36 0.29 0.11 0.04 -- 0.07

Top 10 Holdings (%) as of 02/29/20 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA US
689,931
7,954,904 5.52
NOVO NORDISK A/S
NVO US
135,046
7,850,224 5.45
ABBVIE INC
ABBV US
88,566
7,590,992 5.27
ZOETIS INC
ZTS US
55,931
7,451,687 5.17
JOHNSON & JOHNSON
JNJ US
54,469
7,324,991 5.08
BRISTOL-MYERS SQUIBB CO
BMY US
123,037
7,266,565 5.04
SANOFI
SNY US
156,677
7,246,311 5.03
ELI LILLY & CO
LLY US
57,217
7,216,780 5.01
ASTRAZENECA PLC
AZN US
159,348
6,979,442 4.84
NOVARTIS AG
NVS US
82,535
6,929,639 4.81
Top 10 Total (%) 51.22
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 03/31/20

  • Country

    % of Net Assets
  • United States

    63.34
  • United Kingdom

    11.57
  • Denmark

    5.40
  • Switzerland

    5.21
  • Israel

    4.66
  • France

    4.56
  • Japan

    4.14
  • Ireland

    0.85
  • Other/Cash

    0.26

Sector Weightings (%) as of 03/31/20

  • Sector

    % of Net Assets
  • Health Care

    99.7
  • Other/Cash

    0.3